Showing results (111-120 of 257) with videos related to

Sort By:
Pageof 26
BMC Cancer|August 4, 2016
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutantsSimona Soverini, Caterina De Benedittis, Fausto Castagnetti, et al.
Cancers|April 23, 2022
Sulfur Exafluoride Contrast-Enhanced Ultrasound Showing Early Wash-Out of Marked Degree Identifies Lymphoma Invasion of Spleen with Excellent Diagnostic Accuracy: A Monocentric Study of 260 Splenic NodulesMarco Picardi, Claudia Giordano, Fabio Trastulli, et al.
Leukemia & Lymphoma|July 2, 2011
Cytological and histological detection of amyloid deposits in bone marrow of patients affected by multiple myelomaFara Petruzziello, Pio Zeppa, Giuseppe Ciancia, et al.
The Oncologist|May 25, 2026
Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 studyJean-Jacques Kiladjian, Uma Borate, Elisabetta Abruzzese, et al.
Haematologica|March 28, 2008
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcomeFrancesca Palandri, Ilaria Iacobucci, Fausto Castagnetti, et al.
Drug Design, Development and Therapy|June 2, 2015
Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating studyNicola Cascavilla, Valerio De Stefano, Fabrizio Pane, et al.
Blood|February 1, 2011
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cellsConcetta Quintarelli, Gianpietro Dotti, Sayyeda T Hasan, et al.
Frontiers in Cellular and Infection Microbiology|February 20, 2026
BK polyomavirus-associated progressive multifocal leukoencephalopathy following mogamulizumab therapy for erythrodermic mycosis fungoidesMichele Longo, Fabiana Napolitano, Rosy D'Agostino, et al.
Annals of Hematology|June 16, 2019
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosisMassimo Breccia, Luigiana Luciano, Novella Pugliese, et al.
Haematologica|March 15, 2006
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trialGiuseppe Cimino, Fabrizio Pane, Loredana Elia, et al.
Pageof 26